Our corporate headquarters in Switzerland are located at Rue du Centre 172, CH-1025 Saint-Sulpice, Switzerland and the telephone number is +41 21 694 10 60. Our corporate headquarters in Boston are located at 185 Dartmouth Street, Suite 502, Boston, MA 02116, U.S.A and the telephone number is (617) 982-1210.
SOPHiA Genetics SA was incorporated in Switzerland in 2011.
SOPHiA Genetics SA went public on July 23, 2021.
You can find the public offering prospectus in our Investor Relation section at www.sophiagenetics.com or directly at www.sec.gov.
Our fiscal year end is December 31st.
Our ticker is SOPH and our shares are traded on the NASDAQ exchange. Our shares are not traded on a Swiss exchange.
As of December 31, 2020, we do not pay dividends.
Our transfer agent is Computershare (www.computershare.com/investor). For written requests, their address is P.O. Box 505000, Louisville, KY 40233-5000. For overnight delivery, their address is 462 South 4th Street, Suite 1600, Louisville, KY 40202. Their email is firstname.lastname@example.org and their telephone number is 1-800-736-3001 (U.S., Canada, Puerto Rico) and 1-781-575-3100 (non-U.S.).
Quarterly and annual reports, as well as other SEC filings, can be accessed in the Financial Reports section of our Investor Relations pages at www.sophiagenetics.com or directly from the SEC at www.sec.gov.
You can view our management team by visiting the Executive Team section at www.sophiagenetics.com.
You can view our Board of Directors by visiting the Board of Directors section at www.sophiagenetics.com.
You can contact our Investor Relations team via email at email@example.com.
You can find the latest price of our shares in our Investor Relations section at www.sophiagenetics.com.
Please contact a NASDAQ stockbroker to buy or sell our shares.